These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

869 related items for PubMed ID: 19013353

  • 1. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
    Liu JW, Wang LS, Cheng YJ, Hsu GJ, Lu PL, Liu YC, Chen CM, Lee CM, Sun W, Jang TN, Chiang PC, Chuang YC, Lin HC, Shi ZY, Kung HC, Huang CH, Tsao SM, Lu CT, Liao CH, Hsueh PR.
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
    [Abstract] [Full Text] [Related]

  • 2. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methods.
    Liao CH, Kung HC, Hsu GJ, Lu PL, Liu YC, Chen CM, Lee CM, Sun W, Jang TN, Chiang PC, Cheng YJ, Lin HC, Shi ZY, Wang LS, Chuang YC, Tsao SM, Lu CT, Liu JW, Huang CH, Hsueh PR.
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S192-6. PubMed ID: 19013354
    [Abstract] [Full Text] [Related]

  • 3. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
    Navon-Venezia S, Leavitt A, Carmeli Y.
    J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the Etest and broth microdilution method for tigecycline susceptibility testing against clinical isolates of Acinetobacter baumannii from Taiwan.
    Liu JW, Jang TN, Cheng YJ, Hsu GJ, Sun W, Lu CT, Hsueh PR, Tigecycline In-Vitro Surveillance in Taiwan (TIST) Group.
    Int J Antimicrob Agents; 2010 Feb; 35(2):201-2. PubMed ID: 19892530
    [No Abstract] [Full Text] [Related]

  • 5. In vitro activity of tigecycline against clinical isolates of multidrug-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand.
    Tiengrim S, Tribuddharat C, Thamlikitkul V.
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S102-5. PubMed ID: 17718251
    [Abstract] [Full Text] [Related]

  • 6. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
    Song JY, Kee SY, Hwang IS, Seo YB, Jeong HW, Kim WJ, Cheong HJ.
    J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
    [Abstract] [Full Text] [Related]

  • 7. In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.
    Scheetz MH, Qi C, Warren JR, Postelnick MJ, Zembower T, Obias A, Noskin GA.
    Antimicrob Agents Chemother; 2007 May; 51(5):1621-6. PubMed ID: 17307973
    [Abstract] [Full Text] [Related]

  • 8. Rapid development of Acinetobacter baumannii resistance to tigecycline.
    Reid GE, Grim SA, Aldeza CA, Janda WM, Clark NM.
    Pharmacotherapy; 2007 Aug; 27(8):1198-201. PubMed ID: 17655518
    [Abstract] [Full Text] [Related]

  • 9. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates.
    Seifert H, Stefanik D, Wisplinghoff H.
    J Antimicrob Chemother; 2006 Nov; 58(5):1099-100. PubMed ID: 16980293
    [No Abstract] [Full Text] [Related]

  • 10. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W, Salama M, Dehrab N, Al Hashem G, Shahin M, Rotimi VO.
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii.
    Capone A, D'Arezzo S, Visca P, Petrosillo N, Gruppo Romano Acinetobacter baumannii.
    J Antimicrob Chemother; 2008 Aug; 62(2):422-3. PubMed ID: 18424790
    [No Abstract] [Full Text] [Related]

  • 13. Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem.
    Pachón-Ibáñez ME, Jiménez-Mejías ME, Pichardo C, Llanos AC, Pachón J.
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4479-81. PubMed ID: 15504889
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009.
    Morfin-Otero R, Dowzicky MJ.
    Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546
    [Abstract] [Full Text] [Related]

  • 16. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
    Sheng WH, Wang JT, Li SY, Lin YC, Cheng A, Chen YC, Chang SC.
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan.
    Lee YT, Huang LY, Chiang DH, Chen CP, Chen TL, Wang FD, Fung CP, Siu LK, Cho WL.
    Int J Antimicrob Agents; 2009 Dec; 34(6):580-4. PubMed ID: 19733035
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial.
    Halstead DC, Abid J, Dowzicky MJ.
    J Infect; 2007 Jul; 55(1):49-57. PubMed ID: 17250897
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.